CIK: 0001615982
申告総資産額
$26.8億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Instil Bio, Inc. | 株式-その他 | 18.68% | — | — | |
| 2 | CNST | Constellation Pharmaceutical | 株式-その他 | 10.19% | — | — | |
| 3 | ACRS | Aclaris Therapeutics INC | 株式-その他 | 10.17% | — | +90.32% | |
| 4 | OLMA | Olema Pharmaceuticals INC | 株式-その他 | 5.53% | — | — | |
| 5 | ALT | Altimmune INC | 株式-その他 | 5.37% | — | -22.22% | |
| 6 | CGEM | Cullinan Therapeutics INC | 株式-その他 | 5.32% | +0.02% | — | |
| 7 | KNTEUSD | Kinnate Biopharma INC | 株式-その他 | 4.98% | — | — | |
| 8 | TREUR | Trillium Therapeutics INC | 株式-その他 | 4.71% | — | — | |
| 9 | MRNS* | Marinus Pharmaceuticals INC | 株式-その他 | 4.44% | — | +2.04% | |
| 10 | VTGNUSD | Vistagen Therapeutics INC | 株式-その他 | 3.77% | — | +74.17% | |
| 11 | ✓ | Athira Pharma INC | 株式-その他 | 3.38% | — | — | |
| 12 | RLMD | Relmada Therapeutics INC | 株式-その他 | 3.26% | +1.26% | NEW | |
| 13 | CLDX | Celldex Therapeutics INC | 株式-その他 | 2.77% | — | +55.08% | |
| 14 | PHVS | Pharvaris N.V. | 株式-その他 | 2.75% | — | — | |
| 15 | KROS | Keros Therapeutics INC | 株式-その他 | 2.49% | — | -44.62% | |
| 16 | EPIEUR | Essa Pharma INC | 株式-その他 | 1.97% | — | — | |
| 17 | KURA | Kura Oncology INC | 株式-その他 | 1.76% | — | — | |
| 18 | SNDX | Syndax Pharmaceuticals INC | 株式-その他 | 1.44% | — | -46.94% | |
| 19 | TORCEUR | Adicet Bio INC | 株式-その他 | 1.42% | — | — | |
| 20 | ✓ | 株式-その他 | 1.04% | — | — | ||
| 21 | COGT | Cogent Biosciences INC | 株式-その他 | 1.04% | -0.64% | — | |
| 22 | ✓ | Aligos Therapeutics INC | 株式-その他 | 1.01% | — | +0.86% | |
| 23 | EYPT | Eyepoint INC | 株式-その他 | 0.77% | — | — | |
| 24 | ✓ | Bctg Acquisition CORP | 株式-その他 | 0.60% | — | — | |
| 25 | ✓ | Metacrine INC | 株式-その他 | 0.46% | — | -1.97% | |
| 26 | SPRY | Ars Pharmaceuticals INC | 株式-その他 | 0.40% | — | -43.33% | |
| 27 | TSHA | Taysha Gene Therapies INC | 株式-その他 | 0.27% | — | +11.73% | |
| 28 | VRDN | Viridian Therapeutics INC | 株式-その他 | 0.04% | -3.14% | — |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | ACRS | Aclaris Therapeutics INC | +8.3% | +90.32% | 増加 |
| 2 | VTGNUSD | Vistagen Therapeutics INC | +1.1% | +74.17% | 増加 |
| 3 | CLDX | Celldex Therapeutics INC | +0.7% | +55.08% | 増加 |
| 4 | RLMD | Relmada Therapeutics INC | +0.1% | +27.64% | 増加 |
| 5 | VRDN | Viridian Therapeutics INC | 0% | — | 変化なし |
| 6 | TSHA | Taysha Gene Therapies INC | -0.2% | +11.73% | 増加 |
| 7 | MRNS* | Marinus Pharmaceuticals INC | -0.2% | +2.04% | 増加 |
| 8 | ✓ | Bctg Acquisition CORP | -0.2% | — | 変化なし |
| 9 | ✓ | Metacrine INC | -0.3% | -1.97% | 減少 |
| 10 | SPRY | Ars Pharmaceuticals INC | -0.6% | -43.33% | 減少 |
| 11 | ✓ | Aligos Therapeutics INC | -0.6% | +0.86% | 増加 |
| 12 | COGT | Cogent Biosciences INC | -0.8% | — | 変化なし |
| 13 | KURA | Kura Oncology INC | -1% | — | 変化なし |
| 14 | ALT | Altimmune INC | -2.1% | -22.22% | 減少 |
| 15 | SNDX | Syndax Pharmaceuticals INC | -2.2% | -46.94% | 減少 |
| 16 | KNTEUSD | Kinnate Biopharma INC | -3.6% | — | 変化なし |
| 17 | TREUR | Trillium Therapeutics INC | -4% | — | 変化なし |
| 18 | KROS | Keros Therapeutics INC | -4.5% | -44.62% | 減少 |
| 19 | ✓ | Athira Pharma INC | -5.1% | — | 変化なし |
| 20 | OLMA | Olema Pharmaceuticals INC | -5.3% | — | 変化なし |
| 21 | CNST | Constellation Pharmaceutical | -6.8% | — | 変化なし |
| 22 | ✓ | Instil Bio, Inc. | — | NEW | 新規購入 |
| 23 | CGEM | Cullinan Therapeutics INC | — | NEW | 新規購入 |
| 24 | PHVS | Pharvaris N.V. | — | NEW | 新規購入 |
| 25 | EPIEUR | Essa Pharma INC | — | NEW | 新規購入 |
| 26 | SURFUSD | Surface Oncology INC | — | EXIT | 全売却 |
| 27 | TORCEUR | Adicet Bio INC | — | NEW | 新規購入 |
| 28 | ✓ | — | NEW | 新規購入 | |
| 29 | GRTX | Galera Therapeutics INC | — | EXIT | 全売却 |
| 30 | EYPT | Eyepoint INC | — | NEW | 新規購入 |
| 31 | FPRX | Five Prime Therapeutics INC | — | EXIT | 全売却 |
| 32 | BCABGBP | Bioatla INC | — | EXIT | 全売却 |